icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
The actual benefit of OPTAFLU is substantial.
Clinical Added Value
no clinical added value
In view of the available data, the Transparency Committee considers that the OPTAFLU vaccine does not offer any improvement in actual benefit (IAB V, non-existent) in the prophylaxis of influenza in populations aged over 18 years and covered by the High Council for Public Health guidelines.
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
VsscbAY2U6SDXu5V